Communicable

Communicable

Por: CMI Communications
Communicable takes on hot topics in infectious diseases and clinical microbiology. Hosted by the editors of CMI Communications, the open-access journal of ESCMID, the European Society of Clinical Microbiology & Infectious Diseases.
38 episodios disponibles

Latest episodes of the podcast Communicable

Mostrando página 2 de 2

Communicable E18: The Nightmare Series, part 4 - How to manage polio and rubella 13/01/2025
Communicable E17: Season’s greetings from the editors & holiday replay of late-breaker clinical trials at ESCMID Global 2024 30/12/2024
Communicable E16: Climate change and infections – effects on clinical practice & sustainability 16/12/2024
Communicable E15: Wastewater surveillance – can it really protect us from infections? 02/12/2024
Communicable E14 - Substandard and falsified antimicrobials: what is their effect on patients and on AMR? 18/11/2024
Communicable E13 - The Wild West of publishing today: predatory journals and how to deal with them 04/11/2024
Communicable E12 - The Nightmare Series, part 3: How to deal with vancomycin-resistant enterococci 21/10/2024
Communicable E11 - Nightmare series, part 2: How to deal with carbapenemase producers 07/10/2024
Communicable E10 - Pipeline update: new antibiotics & other antimicrobials that you might actually use 23/09/2024
Communicable E9 - Avian flu: an update 09/09/2024
Communicable E8 - The Nightmare Series, part 1: How to deal with Candida auris 26/08/2024
Communicable E7 - Melioidosis goes global 12/08/2024
Communicable E6 - “Sneaky viruses”: an update on hepatitis B & C before World Hepatitis Day 25/07/2024
Communicable E5 - Beauty is in the 'I' of the beholder: EUCAST updates 15/07/2024
Communicable E4 - The BLING-3 trial & continuous beta-lactam infusion: should these results change your practice? 01/07/2024
Communicable E3 - The new WHO Priority Pathogens List: which bugs to target first? 17/06/2024
Communicable E2 - Phage therapy: does it work and will we have access? 03/06/2024
Communicable E1 - Late-breaker clinical trial results from ESCMID Global 2024: Should they change your practice? 10/05/2024
« Primera ‹ Anterior 1 2
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA